Full name
PHARMACON PARTNER SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA KOMANDYTOWA
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.72.Z - Retail sale of footwear and leather goods
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.20.Z - Rental and management of own or leased real estate
73.11.Z - Advertising agency activities
2020 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 2,1 | 3,2 | 2,9 | -8,1 |
Gross profit (loss) | 2 | 3,3 | 3,3 | 0,9 |
EBITDA | 2 | 3,3 | 3,4 | 0,7 |
Short time liabilities | 1,7 | 1,9 | 2,4 | 27,1 |
Other operating costs | 0,2 | 0,2 | 0,2 | 13 |
Equity capital | 5,8 | 4,1 | 6,8 | 65,6 |
Operating profit (EBIT) | 2 | 3,3 | 3,3 | 0,8 |
Assets | 7,5 | 11,1 | 13 | 16,9 |
Net profit (loss) | 2 | 2,6 | 2,7 | 2,6 |
Cash | 1,1 | 2 | 1,6 | -23,1 |
Net income from sale | 42,5 | 54,2 | 60,7 | 11,9 |
Liabilities and provisions for liabilities | 1,7 | 7 | 6,2 | -11,6 |
Working assets | 7,2 | 11 | 12,9 | 17,2 |
Other income costs | 0,1 | 0,3 | 0,6 | 112,7 |
Depreciation | 0,1 | 0,1 | 0,1 | -1,4 |
% | % | % | p.p. | |
Profitability of capital | 33,9 | 63,9 | 39,6 | -24,3 |
Equity capital to total assets | 77 | 36,9 | 52,3 | 15,4 |
Gross profit margin | 4,6 | 6 | 5,4 | -0,6 |
EBITDA Margin | 4,8 | 6,1 | 5,5 | -0,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 15 | 13 | 14 | 1 |
Current financial liquidity indicator | 4.2003912925720215 | 5.795508861541748 | 5.345755577087402 | -0,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane